Does silencing of RhoA and RhoC expression by RNA interference suppress human colorectal carcinoma growth in vivo?
Recombinant adenovirus mediated RhoA and RhoC shRNA in tandem linked expression may inhibit the growth of human colorectal tumor xenografts in vivo. These results indicate that RhoA and RhoC might be potential targets for gene therapy in colorectal cancer.
By reducing the neutral zone, exogenous cross-linking may help combat the progression of instability in degenerative disc disease.